GlassScriptPhysician profile
Diana Schultz
NPI 1346511557
$2,756.98
in general payments reported to CMS, 2019-2025
33 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $590 · 2022: $814 · 2023: $976 · 2024: $57.05 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.42 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $332.04 | 2021-2023 | |
| Hologic Sales and Service, LLC | $215.95 | 2025 | Fluent Fluid Management System, Acessa Provu System |
| Therapeuticsmd, INC. | $202.44 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $187.92 | 2023 | Myfembree |
| Organon LLC | $138.32 | 2021-2025 | Nexplanon, Jada System |
| Pfizer INC. | $117.96 | 2021-2023 | |
| Astellas Pharma US INC | $106.70 | 2022-2023 | Veozah, Myrbetriq |
| Millicent US INC | $97.02 | 2021-2023 | Intrarosa |
| Agile Therapeutics, INC. | $88.89 | 2021-2022 | |
| Avion Pharmaceuticals | $84.35 | 2022-2023 | Balcoltra |
| Evofem Biosciences, INC. | $72.88 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.92 | 2021-2022 | |
| Myovant Sciences INC. | $67.37 | 2022 | |
| Daiichi Sankyo INC. | $65.75 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $45.11 | 2022-2023 | Accrufer |
| Mylan Pharmaceuticals INC. | $42.21 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $40.75 | 2022-2023 | Vivjoa |
| Exact Sciences Corporation | $38.40 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $35.73 | 2021-2025 | |
| Sage Therapeutics, LLC | $30.17 | 2025 | Zurzuvae |
| Phathom Pharmaceuticals, INC. | $24.54 | 2024 | Voquezna |
| Exeltis, USA INC. | $23.81 | 2023 | Slynd |
| Abbott Laboratories | $22.67 | 2023 | Eterna |
| Janssen Pharmaceuticals, INC | $18.95 | 2023 | Xarelto |
| Ethicon US, LLC | $18.91 | 2022 | |
| Ascend Therapeutics US, LLC | $18.89 | 2023 | |
| Novo Nordisk INC | $18.86 | 2023 | Wegovy |
| Supernus Pharmaceuticals, INC. | $16.45 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $16.32 | 2021 | |
| Currax Pharmaceuticals LLC | $15.38 | 2023 | Contrave |
| Amag Pharmaceuticals, INC. | $15.17 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.